Brian Leaf practices corporate and securities law, with an emphasis on representing high-growth technology and life sciences companies and the investors and investment banks involved with those companies. Brian has counseled clients in connection with registered public offerings of equity (representing both issuers and underwriters), SEC reporting and compliance, Sarbanes-Oxley compliance, corporate governance, mergers and acquisitions, venture capital and other private placement financings, and general corporate counseling. He has been involved with over 50 public offering transactions, including 25+ completed IPOs, in the last five years.   

Download full bio 


  • Super Group Completes Warrant Exchange Offer and Consent Solicitation 

  • MaxCyte – $202 Million IPO 

  • Elevation Oncology – $107 Million IPO 

  • IronNet Agrees to SPAC Merger With LGL Systems Acquisition Corporation 

  • AvePoint to Combine With Apex Technology, a Special Purpose Acquisition Company, at $2 Billion Value 

  • View all


  • Stanford Law School
    JD, with distinction, 2001

  • University of Pennsylvania
    BA, American History
    magna cum laude, 1995

  • University of Pennsylvania
    BS, Economics
    magna cum laude, 1995

Admissions & Credentials



  • American Bar Association

  • American Institute of Certified Public Accountants